Memodyne Official Website › Choosing a memory supplement
Choosing a memory supplementChoosing A Memory Supplement: six questions to ask first
A memory supplement is easy to buy and hard to compare. The six questions below are the ones that separate products you can evaluate from products you cannot: what the panel says, what a blend is allowed to hide, how the amounts compare with the research, what the claim is permitted to mean, who is selling it, and what the way out looks like.
Written by the Memodyne Team at Memoadyne. It applies to every product on this shelf, including the one this desk sells.
1. Does it print a Supplement Facts panel?
The single most useful question, and the one most often skipped.
This is the first question and it disqualifies more products than any other. A panel gives you a serving size, a list of ingredients in descending order of weight, an amount per serving for each, and a percent Daily Value where one exists. With it, you can compare a product against published research. Without it, you are comparing names.
A product whose artwork names ingredients but prints no panel is not necessarily hiding a weak formula. It may simply be a badly assembled marketing pack. But the effect on a buyer is the same either way: no comparison is possible, and any number quoted anywhere is somebody’s inference.
Photograph the back of the bottle before you buy, if you can see it. Ask the seller for a panel. And treat any website that prints an amount for a product without one as the least reliable source you have found, whatever else it gets right.
2. Is it a proprietary blend?
Why a total weight without a breakdown is worth less than it looks.
A proprietary blend prints a total weight for a group of ingredients without breaking it down. It is legal, it is common, and it means the second ingredient in the group could be present at a hundredth of the amount the first one is. Blends exist to protect a formula from being copied, and they protect it from being checked at the same time.
The practical test: count how many of the ingredients on the label you can put a number against. If the answer is none, the ingredient list is a flavour description rather than a specification.
A 2023 review of 103 memory supplements sold in American pharmacies found the category dominated by branded blends whose components are mostly studied for something other than memory. That is the shelf you are standing in front of.
3. How do the amounts compare with the research?
Five ingredients, the amounts their trials used, and what a capsule can hold.
This is the step almost nobody takes, and it is the one that changes decisions. Take each ingredient, find one trial of it, and read the amount that trial used. Then compare it with what is in a serving.
| Ingredient | A published amount | What a capsule can realistically carry |
|---|---|---|
L-arginine | 4 g a day and upward for blood pressure | A gram or two at most, alongside anything else in the capsule |
L-arginine AKG | 12 g a day, split across three doses | A fraction of that, in one daily capsule |
L-citrulline | 1.5 g to 3 g twice a day in the pharmacokinetic work | Again, a fraction, and shared with the other five ingredients |
Niacin | 35 mg is the US upper limit for the supplemental form | Easily carried, which makes it one of the few amounts that can be met |
Calcium | 1,000 mg a day in the big trials | Not achievable in a capsule carrying five other things |
Amounts drawn from the records cited at the foot of this guide. The right column is arithmetic, not a measurement of any particular product.
The pattern this exposes is general: ingredients studied in grams rarely survive the move into a multi-ingredient capsule, and ingredients measured in milligrams often do. A label that prints its amounts lets you run this check in a minute; one that names gram-scale ingredients and prints no amounts is telling you something even when it says nothing.
4. What is the claim allowed to mean?
What the words on the front of the bottle are permitted to promise.
American supplement labels carry structure and function claims: statements about supporting a normal body process. They may not claim to treat, cure or prevent a disease, and they carry a disclaimer saying the FDA has not evaluated them.
- "Supports cognitive health" is a structure and function claim and is permitted.
- "Treats memory loss" is a disease claim and is not.
- "Clinically proven" implies a trial of the finished product. Ask which trial, and be unsurprised if there is not one.
- The FTC health products compliance guidance is the document that governs claims in advertising, and it is readable in an evening.
None of this means a permitted claim is meaningless. It means the claim tells you what the seller is allowed to say, not what the product has been shown to do, and those are different pieces of information.
5. Who is selling it, and 6. how do you get your money back?
Four things a seller should show you, and one thing a long window does not prove.
The last two questions are commercial rather than scientific, and they are the ones a buyer can settle fastest.
- A name, a postal address and a telephone number that a person answers.
- A clear statement of the relationship to the brand: manufacturer, authorised retailer, or reseller.
- The refund terms, written down before the purchase, with the window, the return address and who pays the postage.
- Sources for any figure quoted, so a reader can check one.
A long money-back window is worth real money to a first-time buyer, and it is not evidence about the product. Read it as a commercial decision that shifts risk from you to the seller, and use it: a window nobody uses is worth nothing to anybody.
Finally, hold the whole category against what the published record supports. The US POINTER trial and the FINGER trial both randomised thousands of older adults to lifestyle programmes and measured cognitive differences. The National Institute on Aging publishes a short guide to which memory changes are ordinary. Neither costs anything, and both are better first steps than a purchase.
- Hersant H, He S, Maliha P, Grossberg G. Over the Counter Supplements for Memory: A Review of Available Evidence. CNS Drugs. 2023;37(9):797-817. PMID 37603263. https://pubmed.ncbi.nlm.nih.gov/37603263/
- Health Products Compliance Guidance. U.S. Federal Trade Commission, December 2022. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
- Shiraseb F, Asbaghi O, Bagheri R, Wong A, Figueroa A, Mirzaei K. Effect of l-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials. Adv Nutr. 2022;13(4):1226-1242. PMID 34967840. https://pubmed.ncbi.nlm.nih.gov/34967840/
- Campbell B, Roberts M, Kerksick C, et al. Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult men. Nutrition. 2006;22(9):872-81. PMID 16928472. https://pubmed.ncbi.nlm.nih.gov/16928472/
- Schwedhelm E, Maas R, Freese R, et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol. 2008;65(1):51-9. PMID 17662090. https://pubmed.ncbi.nlm.nih.gov/17662090/
- Minto C, Vecchio MG, Lamprecht M, Gregori D. Definition of a tolerable upper intake level of niacin: a systematic review and meta-analysis of the dose-dependent effects of nicotinamide and nicotinic acid supplementation. Nutr Rev. 2017;75(6):471-490. PMID 28541582. https://pubmed.ncbi.nlm.nih.gov/28541582/
- Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669-83. PMID 16481635. https://pubmed.ncbi.nlm.nih.gov/16481635/
- Baker LD, Espeland MA, Whitmer RA, et al. Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial. JAMA. 2025;334(8):681-691. PMID 40720610. https://pubmed.ncbi.nlm.nih.gov/40720610/
- Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255-63. PMID 25771249. https://pubmed.ncbi.nlm.nih.gov/25771249/
- Memory, Forgetfulness, and Aging: What's Normal and What's Not? National Institute on Aging, National Institutes of Health. https://www.nia.nih.gov/health/memory-loss-and-forgetfulness/memory-forgetfulness-and-aging-whats-normal-and-whats-not
